Myocardial ischemia-reperfusion injury and the influence of inflammation

M Algoet, S Janssens, U Himmelreich, W Gsell… - Trends in cardiovascular …, 2023 - Elsevier
Acute myocardial infarction is caused by a sudden coronary artery occlusion and leads to
ischemia in the corresponding myocardial territory which generally results in myocardial …

Immunity, atherosclerosis and cardiovascular disease

J Frostegård - BMC medicine, 2013 - Springer
Atherosclerosis, the major cause of cardiovascular disease (CVD), is a chronic inflammatory
condition with immune competent cells in lesions producing mainly pro-inflammatory …

The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects

HM Al-Kuraishy, AI Al-Gareeb, HM Saad… - …, 2023 - Springer
Multiple sclerosis (MS) is a chronic progressive disabling disease of the central nervous
system (CNS) characterized by demyelination and neuronal injury. Dyslipidemia is observed …

The mevalonate pathway is a druggable target for vaccine adjuvant discovery

Y Xia, Y Xie, Z Yu, H Xiao, G Jiang, X Zhou, Y Yang… - Cell, 2018 - cell.com
Motivated by the clinical observation that interruption of the mevalonate pathway stimulates
immune responses, we hypothesized that this pathway may function as a druggable target …

Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation

F Bonacina, D Coe, G Wang, MP Longhi… - Nature …, 2018 - nature.com
Cholesterol homeostasis has a pivotal function in regulating immune cells. Here we show
that apolipoprotein E (apoE) deficiency leads to the accumulation of cholesterol in the cell …

Molecular targets of statins and their potential side effects: Not all the glitter is gold

KK Patel, VS Sehgal, K Kashfi - European journal of pharmacology, 2022 - Elsevier
Statins are a class of drugs widely used worldwide to manage hypercholesterolemia and the
prevention of secondary heart attacks. Currently, available statins vary in terms of their …

Atherosclerosis: insights into vascular pathobiology and outlook to novel treatments

MP Wolf, P Hunziker - Journal of cardiovascular translational research, 2020 - Springer
The pathobiology of atherosclerosis and its current and potential future treatments are
summarized, with a spotlight on three central cell types involved:(i) endothelial cells …

MHC class II molecules on the move for successful antigen presentation

N Rocha, J Neefjes - The EMBO journal, 2008 - embopress.org
Major histocompatibility complex class II (MHC II) molecules are targeted to endocytic
compartments, known as MIIC, by the invariant chain (Ii) that is degraded upon arrival in …

Statins increase rifampin mycobactericidal effect

LS Lobato, PS Rosa, JS Ferreira… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Mycobacterium leprae and Mycobacterium tuberculosis antimicrobial resistance has been
followed with great concern during the last years, while the need for new drugs able to …

Statin treatment in multiple sclerosis: a systematic review and meta-analysis

G Pihl-Jensen, A Tsakiri, JL Frederiksen - CNS drugs, 2015 - Springer
Background Multiple sclerosis (MS) is a chronic inflammatory disease that leads to
progressive disability. Statins [hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors] …